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Background: Both aging and obesity have been recognized widely as health conditions that profoundly affect
individuals, families and the society. Aged and obese people often report altered pain responses while underlying
mechanisms have not been fully elucidated. We aim to understand whether spinal microglia could potentially
contribute to altered sensory behavior in aged and obese population.
Results: In this study, we monitored pain behavior in adult (6 months) and aged (17 months) mice fed with diet
containing 10 % or 60 % Kcal fat. The group of young adult (3 months) mice was included as theoretical baseline
control. Compared with lean adult animals, diet-induced-obese (DIO) adult, lean and DIO-aged mice showed
enhanced painful response to heat and cold stimuli, while exhibiting hyposensitivity to mechanical stimulation.
The impact of aging and obesity on microglia properties was evidenced by an increased microglial cell density in
the spinal cords, stereotypic morphological changes and polarization towards pro-inflammatory phenotype.
Obesity strikingly exacerbated the effect of aging on spinal microglia.
Conclusion: Aging/obesity altered microglia properties in the spinal cords, which can dysregulate neuron-microglia
crosstalk and impair physiological pain signal transmission. The inflammatory functions of microglia have special
relevance for understanding of abnormal pain behavior in aged/obese populations.
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People are living longer. The number of older persons
has tripled over the last 50 years; it will be more than
triple again over the next 50 years [1]. We expect to
have more than 20 % of the population over 65 years old
by 2050 [2]. In parallel, obesity has become a global epi-
demic. From 2007 to 2009, the prevalence of obesity was
24.1 % in Canada and 34.4 % in the United States [3].
The number of obese old adults is strongly increasing
over time [4]. As a result of the gradual, lifelong accu-
mulation of a wide variety of molecular and cellular
damages, old people usually cope with a progressive de-
cline in their physical and cognitive functions. Pain is
shown to be a common problem where prevalence rates* Correspondence: Ji.Zhang@mcgill.ca
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elders are at increased odds to develop pain [7].
The mechanisms underlying chronic pain in the elderly
are not fully understood, especially in obese elders. Be-
cause both aging and obesity are associated with a low
grade chronic pro-inflammation [8–10], and inflammation
contributes to the development of abnormal painful be-
havior [11, 12], inflammation could be one of the causal
pathways for altered pain behavior in aging and obesity.
As resident immune cells of the central nervous system
(CNS), microglia perform functions similar to those of tis-
sue macrophages in other organs; they constitute the first
line of defense against any disturbance of local homeosta-
sis [13]. Microglia have been recognized as orchestrators
of the CNS inflammatory response in various disease con-
ditions. However, microglia biology and function are
largely altered in aged brain [14]. Their involvement in the
maintenance of local homeostasis can vary within a
continuum of states from beneficial to detrimental fordistributed under the terms of the Creative Commons Attribution 4.0
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of aging, the impact of obesity on microglia have been
much less well investigated, however, some recent studies
highlighted the potential influence of metabolic disorders,
including obesity on microglia properties [16, 17].
The spinal cord is the first relay site in the transmis-
sion of nociceptive information from the periphery to
the brain. Spinal microglia become activated rapidly fol-
lowing an injury to peripheral nerve. The contribution
of activated spinal microglia in the generation and main-
tenance of injury triggered chronic pain has been well
established [18, 19]. It is thus of importance to under-
stand how aging and obesity affect spinal microglia phe-
notypes and function, and whether such changes could
be related to abnormal sensory behavior in elderly. It
will be intriguing to further understand whether and
how obesity can impact spinal microglia, with or without
priming by aging. In this study, by using C57BL/6 mice
fed with regular or high fat diet, we characterized the
phenotypes of spinal microglia in adult (6 months old)
lean and obese mice, as well as in aged (17 months old)
lean and obese mice. A special attention was paid to
microglia inflammatory properties to understand their
potential contribution to aging and/or obesity associated
impaired sensory behavior in these animals.
Results
Impaired motor and sensory functions in adult obese,
aged and aged-obese mice
Diet-induced obese (DIO) mice and lean mice were
generated by feeding male C57/BL6 mice with diet con-
taining either 60 % or 10 % fat, starting from 3 months old
until the end of the experiments (6 or 17 months). As
depicted in Fig. 1a, while the body weights of lean
3 month-mice were 21.13 ± 0.72 g, those of lean 6 month
and 17 month-mice were 31.02 ± 0.48 g and 33.51 ± 2.08 g
(p < 0.001), respectively. DIO-mice weighed 47.71 ± 2.02 g
at the age of 6 months and 61.67 ± 1.34 g at 17 months,
which was significantly higher than age matched lean con-
trols (p < 0.001, vs. lean 6 month and 17 month-mice, re-
spectively). In general, the impact of aging on body weight
was significantly higher in obese mice than in lean mice.
Long term (either 3 months or 14 months) high fat diet
did not induce overt diabetes as no significant difference in
blood glucose levels was detected among groups (Fig. 1b).
Nevertheless, obesity and aging largely impaired mouse
motor coordination. To compare with observations regard-
ing lean 3 month-mice (122.46 ± 28.84 s), lean 6 month-
mice spent similar time on Rotarod (149 ± 32.90 s) whereas
lean 17 month-mice spent much less time on Rotarod
(47.5 ± 5.19 s). Almost all obese mice failed in Rotarod
test. DIO 6 month-mice stayed on Rotarod for
only12.25 ± 1.16 s; and DIO 17 month-mice for 11.83 ±
2.01 s (p < 0.001, vs. age-matched lean mice) (Fig. 1c).To evaluate the effects of obesity and aging on sensory
behavior, von Frey hairs, acetone and hot plate tests were
used to test mouse responses to mechanical, cold and heat
stimulations respectively. Withdrawal thresholds to von
Frey hairs were higher in lean 17 month-mice (p < 0.001,
1.28 ± 0.10 g) compared to those of lean 3 month-mice,
and those of DIO 6 month-mice (p < 0.05, 1.38 ± 0.15 g)
were also increased compared to age-matched control. In
addition, DIO 17 month-mice (1.60 ± 0.28 g) exhibited
higher withdrawal thresholds (Fig. 1d). This result indicates
that obese and aged mice developed mechanical hyposensi-
tivity. Interestingly, both obese and aged mice demon-
strated hypersensitivity to heat stimulation. In the hot plate
test, the withdrawal latencies from lean 6 month- and
17 month-mice were 8.08 ± 0.06 s (p < 0.01) and 5.65 ±
0.45 s (p < 0.001), respectively, while lean 3 month-mice
could sustain 55 °C heat stimulation for 11.08 ± 0.74 s. In
DIO mice, the withdrawal latency was significantly lower,
5.57 ± 0.39 s (6 months) and 5.56 ± 0.44 s (17 months)
(p < 0.01, vs. lean 6 month-mice) (Fig. 1e). Whilst aging
did not alter mouse response to cold stimulation (lean
3 month-mice: 6.64 ± 1.59 s, lean 6-month mice: 6.90 ±
1.31 s, lean 17 month-mice 5.65 ± 0.45 s), cold hyper-
sensitivity was detected in DIO 6 month-mice, as their
withdrawal duration in acetone test was 13.48 ± 0.96 s
(p < 0.01, vs. lean 6 month-mice). However, the with-
drawal duration in acetone test for DIO 17 month-mice
was surprisingly low (1.43 ± 0.51 s) (Fig. 1f ), although
we cannot exclude biased read-out due to technical
flaws of the acetone test in these extremely fat mice. It
is possible that due to excess weight, their muscle strength
was not strong enough to hold up the paw for extended
periods of time and their paw withdrawal reactions could
be restricted by the size of cubicle containers.
Impact of aging and obesity on microglia properties
and phenotypes
Spinal microglia were immunolabeled by an antibody
against Iba-1, a calcium-binding protein specifically
expressed in microglia. Representative examples of lum-
bar spinal cord dorsal horns from all five groups of mice
revealed an increase of Iba-1+ cell density in lean 17 month-
and DIO 17 month- mice (Fig. 2a). Quantitative analysis
(Fig. 2b) demonstrated that the number of spinal microglia
were similar in lean 3 month- (49.50 ± 2.50), lean 6 month-
(46.10 ± 1.71) and DIO 6 month- (45.07 ± 2.09) mice. How-
ever, aging significantly increased the number of Iba-1+
cells in the spinal cords. Compared to lean 3 month-mice,
the number of microglia in lean 17 month-mice reached
79.00 ± 1.46 (p < 0.001). While obesity did not really affect
the total number of spinal microglia in adult mice, it exac-
erbated strikingly the effect of aging on microglia. Micro-
glial cell density was increased to two times higher in DIO
17 month-mice (143.00 ± 12.94, p < 0.001), comparing with
Fig. 1 Impaired motor and sensory functions in adult obese, aged and aged obese mice. a) Body weight changes were observed in DIO
mice, significantly increased in both DIO 6 and 17 month-mice compared to age-matched lean mice. (n = 6–8/group, ***p < 0.001, lean 6
vs. DIO 6, +++p < 0.001, lean 17 vs. DIO 17, ###p < 0.001, DIO 6 vs. DIO 17, xxx p < 0.001, lean 3 vs. lean 6, 17). b) Blood glucose levels
were not significantly altered after long term high-fat diet (n = 6–8/group). c) Impaired motor coordination was observed in both DIO 6
and 17 month-mice, while lean 17 month-mice stayed less time on Rotarod. (n = 6–8/group, ***p < 0.001, lean 6 vs. DIO 6, +++p < 0.001,
lean 17 vs. DIO 17,) d) Mechanical allodynia was reversed with aging (xxxp < 0.001, lean 3 vs. lean17) and with obesity in 6 month-mice
(n= 6–8/group, *p< 0.05, lean 6 vs. DIO 6). e) Thermal hypersensitivity was observed in DIO 6 month-mice compared to lean 6 month-mice (n= 6–8/
group, **p< 0.01, lean 6 vs. DIO 6) as well as in aged mice (n= 6–8/group, xxp< 0.01, xxxp< 0.001, lean 3 months vs. lean 6, 17 months). f) Cold
hypersensitivity was detected in DIO 6 month-mice (n = 6–8/group, **p < 0.01, lean 6 vs. DIO 6), however, it was significantly reversed in
DIO 17 month-mice (n = 6–8/group, +++p < 0.001, lean 17 vs. DIO 17, ###p < 0.001, DIO 6 vs. DIO 17)
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3 months (49.50 ± 2.50). The impact of aging and obesity
on microglia was also characterized by their morphological
changes (Fig. 2c). Microglia in lumbar spinal cords of lean
3 and 6 month-mice displayed small cell bodies with
long, thin branching processes, while microglia in DIO
6 month-mice exhibited thicker and rigid branches. In
lean and obese 17 month aged mice, microglia had en-
larged cell bodies, retracted and thick processes. Their
cell bodies were usually filled with a large amount of
autofluorescent lipofuscin pigment granules. These
undegradable residues of lysosomal digestion have been
recognized as hallmark of aging [20]. In addition to
that, microglia clusters composed of 4-8 Iba-1+ cells
were observed in both lean and DIO17 month-mice.
They were in amoeboid shape or contained very few,short and highly thickened processes. They were lo-
cated mainly in white matter of spinal cords, with much
less lipofuscin accumulation (Fig. 2d).
To define functional phenotypes of microglia in aged
and obese mice, microglia were further stained with
antibodies against CD86 (T cell co-stimulator molecule
B7.2), iNOS and CD16/32 (IgG receptors III and II, FcγR
III/II), markers of M1 microglia/macrophages. While no
positive signals of CD86 and iNOS were detected on
microglia of any groups of mice (data not shown), the
increase of CD16/32 expression on CD11b+ microglia
was observed in dorsal horns of lumbar spinal cords in
lean and DIO17 month-mice whereas only few CD16/32
positive cells were found in lean 3 month- and lean
6 month-mice (Fig. 3a). Those CD11b and CD16/32
double positive cells in 17 months aged mice were
Fig. 2 Alterations on spinal microglia with aging and obesity. a) Microglia in the dorsal horn of lumbar spinal cord was labeled with Iba1 (red).
While there was no obvious difference among the groups of 3 mo, 6 mo and DIO 6 mo mice, the density of Iba1+ microglia was higher in lean
and DIO 17 month-mice. b) Total number of Iba1+ cells was significantly increased in lean 17 month-mice compared to lean 3 month-mice
(xxxp < 0.001, lean 3 vs. lean 17) which was further increased in DIO 17 month-mice (n = 6–10 section/animal, n = 3 animals/group, +++p < 0.001, lean
17 vs. DIO 17, ###p < 0.001, DIO 6 vs. DIO 17). c) Iba1+ microglia (red) underwent morphological changes with aging and obesity. It was observed that
cell bodies were enlarged (arrowheads) and processes were retracted (arrows) while more lipofuscin granules (yellow) were accumulated
in these enlarged cell bodies with aging and obesity. d) Microglia clusters were found in the spinal cord white matter of aged mice
(square in lean 17 month-mice), not found in lean 3 and 6 month-mice. Confocal scanning images showed that clusters were composed
of 5-7 microglia and contained less lipofuscin granules
Lee et al. Immunity & Ageing  (2015) 12:22 Page 4 of 10mostly localized in superficial laminae (laminae I and II)
of dorsal horns where central afferents of sciatic nerves
terminate. The expression of CD16/32 was further en-
hanced in obese aged (DIO 17 months) mice, in parallel
to an increase of CD11b+ microglia numbers.
Microglia are also CNS professional phagocytes. We
used an antibody against CD68 to determine the amount
of glycoproteins expressed on the lysosomes of tissue
macrophages. As a member of the lysosomal associated
membrane glycoprotein (LAMP) family and also a memberof the scavenger receptor family, the expression of CD68
can reflect, to some extent, the capability of microglia in re-
moving intracellular (autophage) and extracellular (phago-
cytosis) debris. We found an increase of CD68 within
spinal microglia in obese and aged mice, which anatomic-
ally, matched with intracellular aggregation of lipofuscin.
Again obesity aggravated the effect of aging on CD68
expression. It appeared that the increase of CD68 ex-
pression occurred prior to the heap-up of lipofuscin
within microglia (Fig. 3b).
Fig. 3 Functional analysis of spinal microglia with aging and obesity. a) Expression of FcγR III/II (CD16/32) on CD11b+ microglia in the spinal cords.
CD16/32 (red) expression was found in dorsal horns of lumbar spinal cords in aged animals (lean and DIO 17 month-mice), which was colocalized with
CD11b+ microglia (green). Only few CD16/32+/CD11b +microglia was observed in lean 3, 6, and DIO 6 month-mice. b) CD68 expression was closely
associated with lipofuscin accumulation in aged microglia. Arrows indicate CD68 staining (blue, left) and lipofuscin pigments (green, right).
The increased lipofuscin deposit with aging (lean 17 and DIO 17 month-mice) was closely associated with CD68. CD68 signals in obese and
aged mice anatomically matched with intracellular aggregation of lipofuscin
Lee et al. Immunity & Ageing  (2015) 12:22 Page 5 of 10Aging and obesity associated inflammatory response
within the spinal cords
As immune competent cells in the CNS, microglia play
major roles in generating inflammatory response in the
spinal cords. Although some M1 pro-inflammatory markers
were not detectable with immunohistochemistry method,
the increase of pro-inflammatory cytokines in obese and
aged spinal cords was found using real time PCR ap-
proaches. The mRNA levels of pro-inflammatory cytokine
TNF-α was highly increased in lean 17 month-mice com-
pared to lean 3 month-mice (p < 0.01). IL-6 mRNA expres-
sion was increased in DIO 6 month-spinal cords (p < 0.05).
IL-1β was not affected significantly by aging nor by obesity
(p > 0.05). Compared with lean 3 month-mice, the expres-
sion of anti-inflammatory cytokines including IL-10 and
TGF-β were not significantly changed in all settings (lean
6 month-, DIO 6 month-, lean 17 month- and DIO
17 month-mice) (Fig. 4).
Discussion
Abnormal pain behavior was observed in adult obese,
aged lean and aged obese mice in the current study.
More specifically, to compare with adult lean animals,
obese and aged mice showed enhanced painful responses
to heat and cold stimuli, however they became hyposen-
sitive to mechanical von Frey stimulation. The impact of
aging and obesity on microglia properties was evidenced
by increased microglial cell density in the spinal cords,
stereotypical morphological changes and polarization
towards pro-inflammatory phenotype. Together withsystemic inflammation, central inflammatory reaction
mediated essentially by spinal microglia could contribute
to altered pain responses in aged and obese mice.
As we observed in rodents, abnormal pain behavior
has been reported in aging and obese human population.
The prevalence of pain that impedes daily activities in-
creases with age in the Spanish [21], Unites States [22]
and Norwegian [23] population. Comparable prevalence
was also found in Taiwanese communities [24] and in
the Mediterranean region [6]. Several cross-sectional
analysis demonstrated that obesity is strongly associated
with chronic pain in general population [7, 25, 26], as
well as in knee, hip and back pain of older people [27].
The Einstein Aging Study (EAS), a community-based
study in the Bronx, demonstrated that body mass index
(BMI) has a significant dose-dependent relationship with
chronic pain [22]. The data from a longitudinal study [7]
showed that odds of developing pain are higher in
people with higher BMI or waist circumference at base-
line. The link between obesity and pain has been attributed
to greater load on weight-bearing joints, as many obese
people reported lower limb and low back pain [28, 29].
However, obesity associated pain was not exclusively linked
to weight-bearing structures, chronic pain in non-weight-
bearing areas, including chronic head, neck, shoulder and
abdominal pain have also been reported [25] . Metabolic
syndrome [30] and limited mobility [31] have been consid-
ered as potential contributors to abnormal sensory behavior
in obese people. One of the most plausible explanations for
increased prevalence of chronic pain in obese and aging
Fig. 4 Inflammatory mediators in lumbar spinal cord. The mRNA levels of pro-inflammatory cytokine TNF-α was highly increased in lean 17 month-mice
(n = 3/group, xxp < 0.01, lean 3 vs. lean 17). IL-6 mRNA expression was increased in DIO 6 mice (n = 3/group, *p < 0.05, lean 6 vs. DIO 6).
IL-1β was not affected by aging nor by obesity (n = 3/group, p > 0.05). The expression of anti-inflammatory cytokines including IL-10 and
TGF-β were not significantly altered
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inflammation. Indeed, both obesity and aging are associated
with pro-inflammatory states where high levels of C-
reactive protein, IL-6 and TNF were found in the blood
[32, 33]. Whether and how central inflammation mediated
by spinal microglia could contribute to altered sensory re-
sponse in these populations remains to be elucidated.
Microglia turn-over is usually slow. They are long-
lived cells in the CNS, which suggests that microglia
could be susceptible to in situ aging effects occurring
over a normal lifespan. In adult physiological conditions,
microglial cells serve beneficial roles in the CNS. They
act not only as immunological sentinels to fend off po-
tentially dangerous insults, but also as constitutively
neuroprotective glia that help sustain neuronal function
in the CNS. In response to various local and/or systemic
disturbances, they are stage-managers of CNS inflamma-
tory responses. Microglia are also involved in synapse
maintenance and elimination [34], clearance of apoptotic
cells [35] and phagocytosis of cellular debris [36]. As
aging is one of the largest risk factors for many diseases,
aging associated changes in microglia have been postu-
lated to drive pathological progression through a loss of,
or reduced neuroprotection, an increase of neurotox-
icity, and dysregulated response to internal/external sig-
nals [37, 38]. With normal aging, microglia in the brain
exhibit de-ramified morphology, have increased mRNAand protein expression of several inflammatory markers,
such as MHCII, CD68, CD11b/c, and release more pro-
inflammatory cytokines [15, 39]. As microglia show re-
markable anatomical, morphological and functional di-
versity in each area of the CNS [40], different functional
organizations (e.g., brain, spinal cord and retina) harbor-
ing microglia have distinct activation thresholds that are
primed to respond differently to insults. Although age-
related changes in microglia have been explored in the
brain and in the retina, very few, if any [41], of such
studies with regard to the spinal cords have been found
in the literatures. It is however of great value to deter-
mine spinal microglia phenotypes in aging and obese an-
imals and patients, as the spinal cord is critical for the
transmission of pain signals from periphery to the brain.
Understanding aging and obesity related alterations of
spinal microglia biology may illuminate potential contri-
butions of this cell population to aging/obesity associ-
ated sensory disorders.
Our results revealed that aging has a profound effect
on spinal microglia, which was exemplified by a signifi-
cant increase in the number of microglia cells, hyper-
trophic cell bodies filling with lipofuscin and retracting/
shortening processes. They displayed pro-inflammatory
profile which was evidenced by enhanced expression of
cytokine TNF-α and Fcγ receptors (CD16/32). All these
aging-related changes on microglia have a consequence
Lee et al. Immunity & Ageing  (2015) 12:22 Page 7 of 10on disturbing spinal cord homeostasis and functional
outcome. First, it has been well documented that pro-
inflammatory cytokines in the spinal cords contribute to
the central sensitization and pain hypersensitivity [42].
Second, cytokines or activated complement proteins re-
leased during pro-inflammatory reaction enhanced FcγR
expression [43, 44], as we observed in microglia of lean/
obese aged mouse spinal cords. Dysfunction of blood
neural barriers reported in normal aged animals and in
human [45, 46] could allow the entry of plasma proteins
including IgG into the CNS parenchyma. The binding of
Fcγ receptors on microglia to IgG antibodies not only
links the powerful effector of the innate immune system,
e.g. microglia, to the humoral immune response, but also
links it to the adaptive immune responses via the antibody-
antigen immune complexes. Such inflammatory reaction
and antibody-dependent cell-mediated cytotoxicity can
further increase spinal neurons excitability [47]. Third,
aged microglia had shortened and less branched processes,
which probably compromise their ability to survey and
interact continuously with their environment, including
modulating synaptic activities within the spinal cords. It
has been shown that the response of senescent microglia
to extracellular ATP and injury was dysregulated, usually
slower in initiation, but sustained for longer periods of
time [48]. Fourth, microglia in aging spinal cords were
filled with a large amount of lipofuscins. Heavy accumula-
tion of such undegradable cellular wastes can result in pro-
found cellular dysfunction and damage, such as sensitizing
cells to oxidative stress, interfering in phagocytic activity
[20], which could lead to an alteration in local physiological
processes. It appears that the increase of CD68 in aged
mouse spinal microglia occurred prior to the accumulation
of lipofuscins, and intracellular location of CD68 matched
perfectly with the lipofuscin deposition. Such coincidence
might suggest an increased autophage in aged mouse
microglia, which could be responsible for lipofuscin accu-
mulation. In addition to the fact that enhanced autophage
and/or decreased lysosomal proteolytic activity can lead to
intracellular lipofuscin aggregation, it has also been sug-
gested that high concentration of lipofuscins in microglia
might result from the phagocytosis of neurons with
lipofuscin-loaded lysosomes [49]. The impact of obesity
and/or metabolic syndrome on microglia was largely
underexplored. It has been reported that high-fat-diet ex-
posure induced IgG accumulation in hypothalamic micro-
glia [50]. Microglia morphology was found altered in obese
mice deficient of Ifitm (Interferon-induced transmembrane
gene family) proteins [17]. Obesity in aging exacerbates
blood brain barrier dysfunction, neuroinflammation and
oxidative stress in mouse hippocampus [51]. In line with
the findings from the aged brain, our study on the spinal
cords of aged and obese mice revealed that obesity remark-
ably aggravated the damage caused by aging on microglia,including a significant increase of microglia cell density,
profound changes on microglia morphology and lipofuscin
accumulation. Such damage can synergistically connect
obese elderly to sensory impairment.
On the whole, microglia cell reactivity has important
consequences in preserving adult neuronal structure and
function [52]. Aging/obesity associated microglia changes
in the spinal cord dorsal horns can dysregulate microglia-
neuron crosstalk and impair physiological pain signal
transmission. The inflammatory functions of microglia
have special relevance for understanding of abnormal pain
behavior in aged populations. It is, therefore, of import-
ance to identify strategies (e.g., dietary or exercise inter-
vention) to restore microglial cells in the elderly and/or
obese brain/spinal cord to its healthy youthful state.
Materials and methods
Animals
C57BL/6 mice (males, 10-12 weeks old, 20–25 g) were
purchased from the Charles River Laboratories. All ani-
mals were acclimatized to standard laboratory conditions
(14-h light, 10-h dark cycle) and given free access to ro-
dent chow and water. For lean mice, C57BL/6 mice were
kept up to 6 or 17 months while feeding them regular
diet containing 10 % kcal fat, 70 % kcal carbohydrate
and 20 % kcal protein (Research Diets, Inc. D12450B).
Diet-induced obese (DIO) mice were induced by feeding
C57BL/6 mice with high-fat diet containing 60 % kcal
fat, 20 % kcal carbohydrate, 20 % kcal protein (Research
Diets, Inc. D12492). Special diet started from the age of
3 months and kept until the age of 6 or 17 months. Ani-
mal body weight was monitored once per month and
blood glucose levels were measured using a hand-held
glucometer (Contour, Bayer) following over night fasting.
C57BL/6 mice aged 10-12 weeks were used as theoret-
ical baseline control. All mice were housed in 2–4 mice/
cage. All experiments were approved by the Institutional
Animal Care and Use Committee of McGill University
(Permit #5990) and conformed to the ethical guidelines
of the International Association for the Study of Pain.
Behavioral analysis
Mice were habituated to the testing environment 1 to
2 h daily for at least two days before baseline testing.
Rotarod assay was used to assess mouse motor coord-
ination. The task included a speed ramp from 0 to
30 rpm over 60 s, followed by an additional 240 s at the
maximal speed. The time that each animal walked on
the rod before falling was recorded.
Mechanical sensitivity was assessed with calibrated
von Frey hairs (Stoelting) using the up-down method
[53]. Mice were placed on a metal mesh floor with small
Plexiglas cubicle containers and allowed at least 1 h for
habituation before testing. A set of eight calibrated von
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0.008 to 1.40 g of force) were applied to the plantar sur-
face of the hindpaw until they bent. A positive reaction
was recorded if mice exhibited a brisk paw withdrawal
reaction from the stimuli. The threshold force required
to elicit withdrawal of the paw (median 50 % paw with-
drawal) was determined as the average of two tests sepa-
rated by at least 1 h.
Acetone test was performed on mice hind paws to
evaluate cold allodynia. Mice were placed in the same
setting described above for the von Frey test. Total dur-
ation of acetone evoked behaviors (flinching, licking or
biting of their hind paws) was counted during 1 min
after one drop of acetone (~25 μl) application to the
plantar surface of the hindpaw.
Hot plate (55 °C) was used as an unpleasant sensory
heat stimulus to measure thermal hypersensitivity. The
latency to paw-licking, squeaking, or distressful behaviors
was measured.Tissue preparation
Mice were deeply anesthetized with a ketamine/xylazine
mixture. Anesthetized mice were perfused transcardially
with 0.9 % NaCl. Lumbar parts (L4 to L6) of spinal cords
were extracted and immediately stored in -80 °C until
use (for real time (RT)-quantitative PCR analysis). For
histological studies, mice after 0.9 % NaCl transcardial
perfusion were further perfused with 4 % paraformalde-
hyde (PFA) in 0.1 M sodium phosphate buffer at pH 7.4.
Lumbar spinal cords were removed and placed in 4 %
PFA overnight and then transferred to 30 % sucrose for
cryoprotection in -20 °C. Frozen lumbar spinal cords
were cut transversely into 25 μm-thick sections on a
sliding microtome and collected in an anti-freeze solu-
tion (0.05 M sodium phosphate buffer containing 30 %
ethylene glycol and 20 % glycerol, pH7.3).Table 1 Detailed information on the selection of primers for real-tim
Gene NCBI ID # Forward
Primer Sequence
IL1β NM_008361.3 mIL1β-F1 CTATACCTG
IL6 NM_031168.1 mIL6-F1 CTGAAACTT
TNFα NM_013693.2 mTNFα-F1 TTCTGTCTA
IL10 NM_010548.2 mIL10-F1 CTATGCTGC
TGFβ NM_009367.3 mTGFβ-F1 AGAGAAGA
GAPDH NM_008084.2 mGAPDH-F1 GTGAAGGT
NCBI National Center for Biotechnology Information
IL interleukin
TNF tumor necrosis factor
TGF transforming growth factor
GAPDH glyceraldehyde 3-phosphate dehydrogenaseImmunohistochemistry
A standard fluorescent immunohistochemistry (IHC)
protocol was applied to characterize spinal microglia
phenotypes. Free-floating sections were incubated in a
blocking buffer consisting of 3 % goat or rabbit serum,
1 % bovine serum albumin, and 0.25 % Triton X-100 in
Tris-buffered saline (TBS) for 1 h at room temperature
followed by overnight primary antibody incubation at 4 °C.
Sections were then incubated with Alexa Fluor 488, 594 or
647-conjugated secondary antibodies (1:500; Invitrogen)
for 1 h at room temperature followed by 5 min incuba-
tion of 4′, 6-diamidino-2-phenylindole (DAPI) for nu-
clear counterstaining (1:100,000; Sigma). Sections were
mounted onto slides, then coverslipped with Vecta-
shield mounting medium (Vector Laboratories). Rabbit
anti-ionized calcium-binding adaptor molecule-1 (Iba-1)
polyclonal primary antibody (1:1000; Wako Chemicals)
followed by Alexa Fluor 594-conjugated goat anti-rabbit
secondary antibody was used for microglia quantitative
and morphological analysis. Double immunostaining was
performed using rat anti-CD11b (1:500; AbD Serotec) and
goat anti-CD16/32 (1:200; R&D systems) primary anti-
bodies followed by Alexa Fluor 488-conjugated rabbit
anti-rat and 647-conjugated rabbit anti-goat secondary
antibodies respectively. Rabbit Iba-1 and Rat anti-CD68
(1:500; AbD Seroect) primary antibodies were labeled with
Alexa Fluor 594-conjugated goat anti-rabbit and Alexa
Fluor 647-conjugated goat anti-rat secondary antibodies
respectively.
Image processing and analysis
The immunofluorescent staining was examined under
microscope. Images were acquired using an Olympus
BX51 microscope equipped with a color digital camera
(Olympus DP71). Quantitative analysis of the immuno-
fluorescent Iba-1+ cells was performed on images digi-
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to avoid signal saturation. Images were acquired using
20x objectives of the microscope, then the area of interest
(AOI) was placed around superficial laminae (laminae I
and II) in dorsal horn (DH) of lumbar spinal cords, then,
Iba-1+ cells were assessed by manual tracking of microglia-
shaped signals in red co-stained with blue DAPI nuclei. Six
to ten sections per animal were used.
RNA extraction and RT-PCR
Tissue homogenization was performed with tissue ho-
mogenizer beads and a Precellys 24 tissue homogenizer
(Bertin Technologies) using two 20s pulses at 5600 rpm.
Total RNA was extracted from lumbar spinal segments
using single-step RNA isolation method with TRIzol®
Reagent (ambion by Life technologies) following manu-
facturer’s protocols. The ratio of absorbance at 260 and
280 nm was measured by a nanodrop 2000 (Thermo
Scientific) to assess purity and concentration of RNA.
cDNA synthesis was performed using 1 μg of total RNA
with SuperScript III Reverse Transcriptase (Invitrogen,
Burlington, ON). qPCR primers were synthesized by In-
tegrated DNA Technologies, and their specificity was
verified using the GenBank database from the National
Center for Biotechnology Information website. Detailed
information on primers is shown in Table 1. SYBR
Green mix was obtained from Bio-Rad (iTaq, Hercules,
CA). qPCR was performed using a Rotor-Gene Q real-
time PCR cycler (Qiagen, Toronto, ON). Data were
interpreted using the comparative Ct method [54]. All
cytokine data were compared to endogenous glyceral-
dehyde 3-phosphate dehydrogenase.
Statistical analysis
All data were presented as mean ± SEM. For all statis-
tical analysis, unpaired t-tests were performed to meas-
ure differences in pain behaviors, microglia numbers and
inflammatory mediator levels between i) lean 6 month-
and DIO 6 month-mice, ii) lean 17 month- and DIO
17 month-mice, and iii) DIO 6 months and DIO 17 months
aged mice. One-way ANOVA followed by Dunnett’s test
was performed to compare differences among lean animals
(3, 6, 17 months aged mice). The criterion for statistical
significance was p < 0.05.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
SHL, YSW and XQS performed the experiments, analyzed the data, SHL
participated in manuscript writing; JZ conceived, supervised the study and
wrote the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by funding from Natural Sciences and Engineering
Research Council of Canada (NSERC) (355332-11) to JZ. SH Lee is holding aPhD studentship from the Fonds de Recherche Sante Quebec (FRSQ). The
authors would like to thank Dr Yang Mu for assistance in quantitative PCR
experiments.
Author details
1The Alan Edwards Centre for Research on Pain, McGill University, 740
Docteur Penfield Ave, Suite 3200C, Montreal, QC H3A 0G1, Canada.
2Department of Neurology & Neurosurgery, Faculty of Medicine, McGill
University, Montreal, QC H3A 2B4, Canada. 3Faculty of Dentistry, McGill
University, Montreal, QC H3A 0C7, Canada.
Received: 29 July 2015 Accepted: 12 November 2015
References
1. Ageing WP: World Population Ageing: 1950–2050. In: www.un.org/esa/
population/publications/worldageing19502050.
2. Ortman JMV, V. A: An aging nation: the older population in the Unites
States. In. https://www.census.gov/prod/2014pubs/p25-1140.pdf; 2014.
3. Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and
the United States. NCHS Data Brief. 2011;56:1–8.
4. Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in
elderly Americans. J Am Geriatr Soc. 2004;52(11):1907–12.
5. Watkins EA, Wollan PC, Melton 3rd LJ, Yawn BP. A population in pain: report
from the Olmsted County health study. Pain Med. 2008;9(2):166–74.
6. Miro J, Paredes S, Rull M, Queral R, Miralles R, Nieto R, et al. Pain in older
adults: a prevalence study in the Mediterranean region of Catalonia.
Eur J Pain. 2007;11(1):83–92.
7. Heim N, Snijder MB, Deeg DJ, Seidell JC, Visser M. Obesity in older adults is
associated with an increased prevalence and incidence of pain. Obesity
(Silver Spring). 2008;16(11):2510–7.
8. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its
potential contribution to age-associated diseases. J Gerontol A Biol Sci Med
Sci. 2014;69 Suppl 1:S4–9.
9. Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease
susceptibility. Cell. 2015;160(5):816–27.
10. Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as “common soil”
of the multifactorial diseases. Autoimmun Rev. 2011;10(7):369–74.
11. Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic
pain. Nat Rev Drug Discov. 2014;13(7):533–48.
12. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune
activation in persistent pain. Pain. 2001;90(1-2):1–6.
13. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector
cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387–94.
14. Wynne AM, Henry CJ, Godbout JP. Immune and behavioral consequences of
microglial reactivity in the aged brain. Integr Comp Biol. 2009;49(3):254–66.
15. Norden DM, Godbout JP. Review: microglia of the aged brain: primed to be
activated and resistant to regulation. Neuropathol Appl Neurobiol. 2013;
39(1):19–34.
16. Lee JJ, Wang PW, Yang IH, Huang HM, Chang CS, Wu CL, et al. High-fat diet
induces toll-like receptor 4-dependent macrophage/microglial cell activation
and retinal impairment. Invest Ophthalmol Vis Sci. 2015;56(5):3041–50.
17. Wee YS, Weis JJ, Gahring LC, Rogers SW, Weis JH. Age-related onset of obesity
corresponds with metabolic dysregulation and altered microglia morphology
in mice deficient for Ifitm proteins. PLoS One. 2015;10(4):e0123218.
18. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. Expression of
CCR2 in both resident and bone marrow-derived microglia plays a critical
role in neuropathic pain. J Neurosci. 2007;27(45):12396–406.
19. Calvo M, Bennett DL. The mechanisms of microgliosis and pain following
peripheral nerve injury. Exp Neurol. 2012;234(2):271–82.
20. Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation
and influence on cell function. Free Radic Biol Med. 2002;33(5):611–9.
21. Catala E, Reig E, Artes M, Aliaga L, Lopez JS, Segu JL. Prevalence of pain in
the Spanish population: telephone survey in 5000 homes. Eur J Pain. 2002;
6(2):133–40.
22. McCarthy LH, Bigal ME, Katz M, Derby C, Lipton RB. Chronic pain and obesity in
elderly people: results from the Einstein aging study. J Am Geriatr Soc. 2009;
57(1):115–9.
23. Rustoen T, Wahl AK, Hanestad BR, Lerdal A, Paul S, Miaskowski C. Prevalence
and characteristics of chronic pain in the general Norwegian population.
Eur J Pain. 2004;8(6):555–65.
Lee et al. Immunity & Ageing  (2015) 12:22 Page 10 of 1024. Yu HY, Tang FI, Kuo BI, Yu S. Prevalence, interference, and risk factors for
chronic pain among Taiwanese community older people. Pain Manag Nurs.
2006;7(1):2–11.
25. Patterson RE, Frank LL, Kristal AR, White E. A comprehensive examination of
health conditions associated with obesity in older adults. Am J Prev Med.
2004;27(5):385–90.
26. Paulis WD, Silva S, Koes BW, van Middelkoop M. Overweight and obesity are
associated with musculoskeletal complaints as early as childhood: a systematic
review. Obes Rev. 2014;15(1):52–67.
27. Andersen RE, Crespo CJ, Bartlett SJ, Bathon JM, Fontaine KR. Relationship
between body weight gain and significant knee, hip, and back pain in older
Americans. Obes Res. 2003;11(10):1159–62.
28. Ibrahimi-Kacuri D, Murtezani A, Rrecaj S, Martinaj M, Haxhiu B. Low back
pain and obesity. Med Arch. 2015;69(2):114–6.
29. Bout-Tabaku S, Briggs MS, Schmitt LC. Lower extremity pain is associated
with reduced function and psychosocial health in obese children.
Clin Orthop Relat Res. 2013;471(4):1236–44.
30. Shin D. Association between metabolic syndrome, radiographic knee
osteoarthritis, and intensity of knee pain: results of a national survey. J Clin
Endocrinol Metab. 2014;99(9):3177–83.
31. Mottram S, Peat G, Thomas E, Wilkie R, Croft P. Patterns of pain and mobility
limitation in older people: cross-sectional findings from a population survey
of 18,497 adults aged 50 years and over. Qual Life Res. 2008;17(4):529–39.
32. Guarner V, Rubio-Ruiz ME. Low-grade systemic inflammation connects
aging, metabolic syndrome and cardiovascular disease. Interdiscip Top
Gerontol. 2015;40:99–106.
33. Asztalos BF, Horan MS, Horvath KV, McDermott AY, Chalasani NP, Schaefer
EJ. Obesity associated molecular forms of C-reactive protein in human.
PLoS One. 2014;9(10):e109238.
34. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia
directly monitor the functional state of synapses in vivo and determine the
fate of ischemic terminals. J Neurosci. 2009;29(13):3974–80.
35. Petersen MA, Dailey ME. Diverse microglial motility behaviors during
clearance of dead cells in hippocampal slices. Glia. 2004;46(2):195–206.
36. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly
dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):
1314–8.
37. Derecki NC, Katzmarski N, Kipnis J, Meyer-Luehmann M. Microglia as a critical
player in both developmental and late-life CNS pathologies. Acta Neuropathol.
2014;128(3):333–45.
38. Streit WJ, Xue QS, Tischer J, Bechmann I. Microglial pathology. Acta Neuropathol
Commun. 2014;2:142.
39. Hanisch UK. Functional diversity of microglia - how heterogeneous are they
to begin with? Front Cell Neurosci. 2013;7:65.
40. Hart AD, Wyttenbach A, Perry VH, Teeling JL. Age related changes in
microglial phenotype vary between CNS regions: grey versus white matter
differences. Brain Behav Immun. 2012;26(5):754–65.
41. Ritzel RM, Patel AR, Pan S, Crapser J, Hammond M, Jellison E, et al. Age- and
location-related changes in microglial function. Neurobiol Aging.
2015;36(6):2153–63.
42. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central
sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6,
and tumor necrosis factor-alpha in regulating synaptic and neuronal activity
in the superficial spinal cord. J Neurosci. 2008;28(20):5189–94.
43. Karehed K, Dimberg A, Dahl S, Nilsson K, Oberg F. IFN-gamma-induced
upregulation of Fcgamma-receptor-I during activation of monocytic cells
requires the PKR and NFkappaB pathways. Mol Immunol. 2007;44(4):615–24.
44. Atkinson JP. C5a and Fcgamma receptors: a mutual admiration society.
J Clin Invest. 2006;116(2):304–6.
45. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al.
Blood-brain barrier breakdown in the aging human hippocampus. Neuron.
2015;85(2):296–302.
46. Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, et al. Blood-brain
barrier dysfunction developed during normal aging is associated with
inflammation and loss of tight junctions but not with leukocyte recruitment.
Immun Ageing. 2015;12:2.
47. Koller H, Siebler M, Hartung HP. Immunologically induced electrophysiological
dysfunction: implications for inflammatory diseases of the CNS and PNS.
Prog Neurobiol. 1997;52(1):1–26.48. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT.
Age-related alterations in the dynamic behavior of microglia. Aging Cell.
2011;10(2):263–76.
49. Nakanishi H, Wu Z. Microglia-aging: roles of microglial lysosome- and
mitochondria-derived reactive oxygen species in brain aging. Behav Brain
Res. 2009;201(1):1–7.
50. Yi CX, Tschop MH, Woods SC, Hofmann SM. High-fat-diet exposure induces
IgG accumulation in hypothalamic microglia. Dis Model Mech. 2012;5(5):
686–90.
51. Tucsek Z, Toth P, Sosnowska D, Gautam T, Mitschelen M, Koller A, et al.
Obesity in aging exacerbates blood-brain barrier disruption,
neuroinflammation, and oxidative stress in the mouse hippocampus:
effects on expression of genes involved in beta-amyloid generation and
Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. 2014;69(10):1212–26.
52. Johnson RW. Feeding the beast: can microglia in the senescent brain be
regulated by diet? Brain Behav Immun. 2015;43:1–8.
53. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment
of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63.
54. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods.
2001;25(4):402–8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
